News and Trends 24 Mar 2023
Metabolism of RNA linked to leukemia
Researchers at Lund University Faculty of Medicine in Sweden have determined a novel mechanism linking the metabolism of ribonucleic acids,…
-
News and TrendsMarch 24, 2023Evotec receives $6.6M for tuberculosis drug discovery
-
OpinionMarch 24, 2023PAN-TB regimens to address growing TB drug resistance
-
Best in BiotechMarch 24, 2023Tuberculosis research: 5 positive advancements over the past year
-
News and TrendsMarch 24, 2023Beyond Biotech podcast 39: World Tuberculosis Day
- Latest Posts
-
News and Trends 24 Mar 2023Microbiome therapeutics biotech mbiomics raises €13M
mbiomics GmbH, a German microbiome biotech company developing the first generation of effective microbiome-based therapeutics has closed €13 million ($…
News and Trends 23 Mar 2023OncoC4 and BioNTech partner in the commercialization of cancer drug candidate
German biopharma BioNTech has closed a licensing deal with the U.S.-based clinical-stage company OncoC4 for the development and commercialization of…
News and Trends 23 Mar 2023Gut microbiota to be harnessed as a tool to diagnose diseases
A recent study at the University of Jyväskylä in Finland compared the gut microbiota and gut-derived metabolites between healthy controls…ADVERTISEMENT
News and Trends 23 Mar 2023Intracellular “smoke detector” discovery has skin disease therapy implications
A study by the University of Bonn in Germany could lead to therapies against skin and intestinal diseases in the…
News and Trends 23 Mar 2023LIfT BioSciences hails breakthrough data for treating solid tumors
LIfT BioSciences has announced what it says are exciting preclinical data demonstrating that its immunomodulatory alpha neutrophil product (IMANp) possesses both…
News and Trends 23 Mar 2023Flare Therapeutics sees $123M oncology boost
Flare Therapeutics Inc., a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases, has announced…
Best in Biotech 23 Mar 2023Hearing loss research: Five advancements in the past year
At present, more than 1.4 billion people live with hearing loss globally. Hearing disorders are often caused by aging, frequent…
Best in Biotech 22 Mar 20236 cultured meat companies making waves
An unsustainable demand for meat has led to companies looking for alternative solutions to conventional farming methods in order to…
Sponsored by Scientist.com22 Mar 2023Streamlining supplier qualification with a more efficient on-site pre-assessment process
Quality assurance in drug development programs is critical to ensuring a potentially life-saving drug reaches patients in time. In a…ADVERTISEMENT
News and Trends 21 Mar 2023Etana secures funding for oncology pipeline
PT Etana Biotechnologies Indonesia (Etana), an Indonesian biopharmaceutical company, has secured a new round of investment led by DEG followed…
Best in Biotech 21 Mar 20235 advancements in Down syndrome research over the past year
It was in 1959 when an extra chromosome on the 21st pair in the human cell was discovered by French…
News and Trends 21 Mar 2023Karuna Therapeutics sees positive schizophrenia trial results
Karuna Therapeutics, Inc. has announced positive topline results from its phase 3 EMERGENT-3 trial evaluating the efficacy, safety, and tolerability…
News and Trends 21 Mar 2023Campbell Neurosciences creates saliva-based test for suicidal thoughts
Therapeutic Solutions International (TSOI) has announced that its spin-off biotech company, Campbell Neurosciences, Inc., obtained successful validation of its suicidal…
News and Trends 20 Mar 2023SpyBiotech receives more than $4 million to develop vaccine platform
UK-based SpyBiotech has received a grant of more than $4 million from the Bill & Melinda Gates Foundation to build…
Expert Advice 20 Mar 2023Nine tips to succeed in pharma-biotech partnerships
The question of whether to partner with another company is critical to the long-term development of a biotech. Nonetheless, it…ADVERTISEMENT
Best in Biotech 17 Mar 202367% five-year survival rate in glioblastoma therapy, according to CANbridge Pharmaceuticals study
CANbridge Pharmaceuticals Inc. has announced that its therapy for glioblastoma has shown a 67% survival rate at five years, three…
News and Trends 17 Mar 2023Likang gets trial ok for China’s first personalized cancer vaccine
Likang Life Sciences has received implied approval for the clinical trial of its personalized neoantigen-targeted vaccine for advanced solid tumors,…
News and Trends 17 Mar 2023Purple Biotech sees positive results from cancer study
Purple Biotech Ltd. has released new results from exploratory analyses conducted as part of a phase 1 dose escalation study…
News and Trends 17 Mar 2023Beyond Biotech podcast 38: Hello Tomorrow Global Summit
The Hello Tomorrow Global Summit took place in Paris last week (March 8-10), and we feature interviews with four of…
